Our new website is online.

On 1 July 2008, Eczacıbaşı Pharmaceuticals Manufacturing successfully concluded its acquisition of a 50 percent share in Monrol Nuclear Products Industry and Trade.
Ürünler

Ürünler

Eczacıbaşı-Monrol Nuclear Products realized the production of F18 FDG in 2001 (Florodeoksi-D-glucose) required for the PET (Positron Emission Tomography) which was developed in the world. They also produce the radiopharmaceutical used in SPECT (Single Photon Emission Computed Tomography). 

Nükleer Tıp

Nükleer TıpPositron Emission Tomography (PET Imaging)

What is Nuclear Medicine?

Why do radioactive materials are required for diagnose and treatment of diseases? Do materials used in nuclear medicine inflict any harm?

[February 06, 2009]  IBA and Eczacıbaşı-Monrol Join Forces to Grow Market for Radiopharmaceuticals in Several Regions

[]  9th Asia Oceania Congress of Nuclear Med.and Biology (www.snmindia.org) (31 Ekim -4 Kasım) Hindistan/New Delhi

[11-15.10.2008]  EANM'08 ANNUAL CONGRESS OF THE EUROPEAN ASSOCIATION OF NUCLEAR MEDICINE October 11-15, 2008 - Münich Germany

[01.07.2008]  On 1 July 2008, Eczacıbaşı Pharmaceuticals Manufacturing successfully concluded its acquisition of a 50 percent share in Monrol Nuclear Products Industry and Trade.

[04-07.05.2008]  We participated at ISEP 2008
CONTACT INFORMATION REPRESENTATIVES IN OTHE COUNTRIES LOCAL REPRESENTATIVES